Universidad del País Vasco/Euskal Herriko Unibertsitatea-ko ikertzaileekin lankidetzan egindako argitalpenak (19)

2012

  1. Population pharmacokinetics of prophylactic cefoxitin in patients undergoing colorectal surgery

    European Journal of Clinical Pharmacology, Vol. 68, Núm. 5, pp. 735-745

1998

  1. Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer

    Cancer Chemotherapy and Pharmacology, Vol. 42, Núm. 5, pp. 418-422

1997

  1. Pharmacokinetic-pharmacodynamic modeling of mivacurium in rats

    Journal of Pharmaceutical Sciences, Vol. 86, Núm. 2, pp. 252-256

1996

  1. Pharmacokinetics and pharmacodynamics of penbutolol in healthy and cancer subjects: Role of altered protein binding

    Research Communications in Molecular Pathology and Pharmacology, Vol. 92, Núm. 1, pp. 53-72

  2. Population-based approach to the assessment of pharmacokinetic-pharmacodynamic data

    Methods and Findings in Experimental and Clinical Pharmacology

1995

  1. Resistance to atracurium in rats with experimental inflammation: role of protein binchng

    Acta Anaesthesiologica Scandinavica, Vol. 39, Núm. 8, pp. 1019-1023

  2. Tenoxicam pharmacokinetics in rats: A population model

    Journal of Pharmaceutical Sciences, Vol. 84, Núm. 12, pp. 1482-1487